An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation

PHASE3CompletedINTERVENTIONAL

Enrollment

1,774

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2005

Conditions

EjaculationErectile DysfunctionSexual Dysfunction

Interventions

DRUG

dapoxetine

60 mg tablet once daily as needed (prn) (with a possible dose reduction to 30 mg once daily) for up to 9 months

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT01230762 - An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation | Biotech Hunter | Biotech Hunter